The retailer’s negotiations with Franchise Group have come to an end, it revealed in a release, due to the current financing and retail environment, and its board has “unanimously determined to conclude its strategic review process.” During the three-week period when FRG was conducting due diligence and negotiations were supposed to be finalized, the owner of The Vitamin Shoppe and other retailers reduced its offer to $53 per share from $60, KSS said, and did not have definitive financing arrangements in place for even the lower price. The prospects for another suitor stepping up are dim, the Kohl’s board believes, ... Log in to view full article.